CanSino Biologics Inc. (HKG:6185)

CanSino Biologics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	13,814	12,632	11,610	12,514	27,690	66,111
Market Cap Growth	19.80%	8.81%	-7.23%	-54.81%	-58.12%	-11.15%
Enterprise Value	12,294	11,140	10,302	10,611	23,868	58,920
Last Close Price	33.94	34.92	31.50	23.55	66.75	177.89
PE Ratio	277.27	407.26	-	-	-	28.13
Forward PE	21.15	45.28	-	-	-	11.16
PS Ratio	11.62	10.63	12.89	31.81	23.68	12.53
PB Ratio	2.52	2.30	2.22	2.15	3.38	6.30
P/TBV Ratio	2.62	2.40	2.28	2.21	3.75	6.89
P/FCF Ratio	-	-	-	-	-	63.60
P/OCF Ratio	-	-	-	-	-	26.27
EV/Sales Ratio	10.35	9.37	11.44	26.97	20.41	11.16
EV/EBITDA Ratio	52.77	47.82	-	-	-	25.96
EV/EBIT Ratio	-	418.60	-	-	-	26.91
EV/FCF Ratio	-	-	-	-	-	56.68
Debt / Equity Ratio	0.29	0.29	0.41	0.51	0.37	0.16
Debt / EBITDA Ratio	6.81	6.81	-	-	-	0.74
Debt / FCF Ratio	-	-	-	-	-	1.62
Net Debt / Equity Ratio	-0.28	-0.28	-0.24	-0.27	-0.45	-0.75
Net Debt / EBITDA Ratio	-6.52	-6.52	6.15	0.97	2.46	-3.46
Net Debt / FCF Ratio	-	-	1.91	0.94	1.11	-7.57
Asset Turnover	-	-	0.10	0.03	0.09	0.46
Inventory Turnover	-	-	0.83	1.55	1.57	2.48
Quick Ratio	-	-	2.38	1.86	2.33	2.78
Current Ratio	-	-	2.54	2.02	2.64	3.25
Return on Equity (ROE)	0.57%	0.57%	-7.52%	-31.40%	-12.22%	26.09%
Return on Assets (ROA)	-	-	-2.74%	-10.36%	-8.03%	11.97%
Return on Invested Capital (ROIC)	0.67%	0.66%	-10.02%	-43.85%	-48.83%	108.45%
Return on Capital Employed (ROCE)	-	-	-6.00%	-25.50%	-17.50%	19.80%
Earnings Yield	0.22%	0.25%	-3.47%	-13.05%	-3.71%	3.55%
FCF Yield	-	-	-5.73%	-13.37%	-11.95%	1.57%
Dividend Yield	-	-	-	-	-	0.55%
Payout Ratio	-	-	-	-	-	0.74%
Buyback Yield / Dilution	-2.32%	-2.32%	-0.38%	0.17%	0.08%	-7.26%
Total Shareholder Return	-2.32%	-2.32%	-0.38%	0.17%	0.08%	-6.70%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.